The Clorox Company (CLX) earnings on August 3, 2026
More The Clorox Company earnings
Prior outlook: Pessimistic Outcome: Partial
The stock jumped after reporting earnings, climbing as much as 6.70% and finishing up 6.52%. Some investors had expected a drop, but the results surprised to the upside.
CLX price around the earnings
104.67
Change: +6.5%
2026-08-04, 20:00 UTC
Start of the measured window
End of the measured window
95.63
98.69
101.74
104.80
98.26
August 3, 2026
August 4, 2026
- Price: green if it ends above the starting price; red if it ends below
- Start of the measured window
- End of the measured window
- Market open
- No trading (market closed)
- Starting price
Prior thesis
Prior outlook: Pessimistic Outcome: Partial
- Thesis published
- Results released
Strong historical earnings and a dividend raise are offset by analyst downgrades and flat growth projections.
Context analyzed before publication
- Trend
- Negative and fluctuating trajectory, showing a moderate sell-off into earnings despite strong historical beats.
Analysts
Evidence
- Analyst consensus
- Hold
- Consensus average (1-5)
- 3.21
- Analysts covering the stock
- 17
- Average price target
- 102.35
- Lowest price target
- 77
- Highest price target
- 155
- Upside to price target
- 3.9%
- Quarterly earnings growth
- 0.5%
- Revenue growth
- 0.1%
- Forward EPS
- 5.95
- Trailing EPS
- 6.15
- Analyst moves in the last 60 days
- 6
- Strong buy: 0
- Buy: 1
- Hold: 14
- Sell: 2
- Strong sell: 2
- Strong buy
- 0
- Buy
- 1
- Hold
- 14
- Sell
- 2
- Strong sell
- 2
- July 28, 2026 · Jefferies: Downgrades rating (Buy → Hold)
- July 23, 2026 · Evercore ISI Group: Maintains rating (Underperform → Underperform)
- July 21, 2026 · Barclays: Maintains rating (Underweight → Underweight)
- July 20, 2026 · BNP Paribas: Maintains rating (Neutral → Neutral)
- July 16, 2026 · JP Morgan: Maintains rating (Underweight → Underweight)
- July 16, 2026 · UBS: Maintains rating (Neutral → Neutral)
News and sentiment
Evidence
Sentiment
- Sentiment
- Constructive
- Mention volume
- High
- Normalized volume
- 99%
News
Sources (8)
- Top Wall Street Forecasters Revamp Clorox Expectations Ahead Of Q4 Earnings (opens in a new tab) — Benzinga
- Clorox Board Raises Quarterly Dividend From $1.24 To $1.25 Per Share (opens in a new tab) — Benzinga
- This Clorox Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday (opens in a new tab) — Benzinga
- Jefferies Downgrades Clorox to Hold, Lowers Price Target to $98 (opens in a new tab) — Benzinga
- Evercore ISI Group Maintains Underperform on Clorox, Lowers Price Target to $98 (opens in a new tab) — Benzinga
- Barclays Maintains Underweight on Clorox, Raises Price Target to $86 (opens in a new tab) — Benzinga
- BNP Paribas Maintains Neutral on Clorox, Lowers Price Target to $95 (opens in a new tab) — Benzinga
- JP Morgan Maintains Underweight on Clorox, Lowers Price Target to $92 (opens in a new tab) — Benzinga
Technicals
Evidence
- Price when the context was analyzed
- 95.53
- Average true range (ATR)
- 2.9%
- Distance to 52-week high
- -21.6%
- 14-day change (14d)
- -0.8%
- 30-day change (30d)
- -1.0%
- 30-day relative strength
- -1.1%
- SPY change (30d)
- +0.1%
- Nearest support
- 95.23
- Distance to nearest support
- 0.3%
- Nearest resistance
- 95.9
- Distance to nearest resistance
- 0.4%
- Volume accumulation ratio (14d / 46d)
- 0.83
- Mid: 95.23 (0.3% away, 0.11 ATR, 15 touches)
- Mid: 94.55 (1% away, 0.35 ATR, 13 touches)
- Mid: 93.91 (1.7% away, 0.58 ATR, 17 touches)
- Mid: 95.89 (0.4% away, 0.13 ATR, 33 touches)
- Mid: 96.48 (1% away, 0.34 ATR, 31 touches)
- Mid: 97.17 (1.7% away, 0.59 ATR, 18 touches)
Trends
Evidence
- Average earnings surprise
- +10.5%
- April 30, 2026: actual EPS 1.64 vs estimate 1.54 (surprise +6.2%)
- February 3, 2026: actual EPS 1.39 vs estimate 1.43 (surprise -3.0%)
- November 3, 2025: actual EPS 0.85 vs estimate 0.78 (surprise +9.2%)
- July 31, 2025: actual EPS 2.87 vs estimate 2.21 (surprise +29.8%)
Expected move
- Implied move
- +2.4%
- Source
- Options chain
Reactions over its last 20 earnings
- Median move
- 5.6%
- 75th percentile move
- 7.8%
- 90th percentile move
- 9.7%
- Up / down moves
- 11 / 9
- Average up move
- +4.7%
- Average down move
- -6.8%
Monitoring and close
What The Clorox Company reported
- Status
- Finished
| Actual EPS | 1.66 |
|---|---|
| EPS estimate | 1.65 |
| EPS surprise | +0.6% |
| Revenue | $1,948 million |
| Revenue estimate | $1,898 million |
| Revenue surprise | +2.6% |
Clorox beat Q4 expectations and provided optimistic FY2027 guidance above estimates. Sustained execution remains key to the next move. Debt and risks persist.
Sources (4)
- Clorox Sees FY2027 GAAP EPS $5.41-$5.71 (opens in a new tab) — Benzinga
- Clorox Sees FY2027 Adj EPS $5.70-$6.00 vs $5.97 Est; Sees Sales $7.594B-$7.661B vs $7.501B Est (opens in a new tab) — Benzinga
- Clorox beat expectations in Q4: adjusted earnings of $1.66 per share and sales of $1.948 billion, above forecasts. — Benzinga
- Clorox Q4 Adj. EPS $1.66 Beats $1.65 Estimate, Sales $1.948B Beat $1.898B Estimate (opens in a new tab) — Benzinga
Pre-market second reading after the results
- Verdict
- Beat expectations
Heading into the open, results beat expectations on both earnings and revenue, and the price is indicating +1.3% pre-market, a move below the stock's usual reaction (about 6%). The figures don't confirm the prior scenario: the comparable cases aren't consistent enough.
How the stock reacted
- Outcome
- Partial
- Consolidated
- +6.5%
- Max favorable move (MFE)
- 2.7%
- Max adverse move (MAE)
- 6.7%